These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32208408)

  • 1. Type 3 diabetes (Alzheimer's disease): new insight for promising therapeutic avenues.
    Candasamy M; Mohamed Elhassan SA; Kumar Bhattamisra S; Hua WY; Sern LM; Binti Busthamin NA; Mohamad Ilni NB; Shun NS; Baohong L; Ya NS; Ying NW
    Panminerva Med; 2020 Sep; 62(3):155-163. PubMed ID: 32208408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Glucose Metabolism in Alzheimer's Disease.
    Calsolaro V; Edison P
    Recent Pat Endocr Metab Immune Drug Discov; 2016; 10(1):31-39. PubMed ID: 27306508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline.
    Walker JM; Harrison FE
    Nutrients; 2015 Sep; 7(9):7332-57. PubMed ID: 26340637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Insulin Resistance in the Alzheimer's Disease Progression.
    Nguyen TT; Ta QTH; Nguyen TTD; Le TT; Vo VG
    Neurochem Res; 2020 Jul; 45(7):1481-1491. PubMed ID: 32314178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide Protects Against Brain Amyloid-β
    Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
    Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance: a connecting link between Alzheimer's disease and metabolic disorder.
    Kshirsagar V; Thingore C; Juvekar A
    Metab Brain Dis; 2021 Jan; 36(1):67-83. PubMed ID: 32986168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Diabetes: a Therapeutic Strategy for Alzheimer's Disease?
    Ahn KC; Learman CR; Baker GB; Weaver CL; Chung PS; Kim HG; Song MS
    J Korean Med Sci; 2019 Dec; 34(46):e297. PubMed ID: 31779058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.
    Yang Y; Ma D; Wang Y; Jiang T; Hu S; Zhang M; Yu X; Gong CX
    J Alzheimers Dis; 2013; 33(2):329-38. PubMed ID: 22936005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic linkage between Alzheimer's disease and type 2 diabetes.
    Nedjadi T; Haque A; Alam Q; Gan SH; Chaudhary AG; Abuzenadah AM; Damanhouri GA; Kamal MA
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):203-12. PubMed ID: 24059319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic insight into the role of metformin in Alzheimer's disease.
    Sanati M; Aminyavari S; Afshari AR; Sahebkar A
    Life Sci; 2022 Feb; 291():120299. PubMed ID: 34999113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
    Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM
    FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations on oxidative stress and therapeutical implications in dementia.
    Durany N; Münch G; Michel T; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():68-73. PubMed ID: 10654103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling.
    Kang S; Kim CH; Jung H; Kim E; Song HT; Lee JE
    Neuropharmacology; 2017 Feb; 113(Pt A):467-479. PubMed ID: 27810390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of insulin resistance in Alzheimer's disease.
    Cai Z; Xiao M; Chang L; Yan LJ
    Metab Brain Dis; 2015 Aug; 30(4):839-51. PubMed ID: 25399337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology, Risk Factors, and Oxidative Damage Related to Type 2 Diabetes-Mediated Alzheimer's Disease and the Rescuing Effects of the Potent Antioxidant Anthocyanin.
    Khan MS; Ikram M; Park TJ; Kim MO
    Oxid Med Cell Longev; 2021; 2021():4051207. PubMed ID: 33728019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties.
    Siddiqui A; Shah Z; Jahan RN; Othman I; Kumari Y
    Biomed Pharmacother; 2021 Dec; 144():112250. PubMed ID: 34607104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
    Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
    Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.